Rennova Health Inc
(RNVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 2,826 | 3,606 | 1,145 | 1,936 | 1,010 |
| Cost of Goods | 1,824 | 1,572 | 1,375 | 1,218 | 1,208 |
| Gross Profit | 1,003 | 2,035 | -230 | 717 | -198 |
| Operating Expenses | 2,751 | 2,569 | 2,064 | 3,241 | 2,362 |
| Operating Income | -925 | 37 | -1,919 | -2,305 | -2,352 |
| Interest Expense | 605 | 479 | 621 | 683 | 701 |
| Other Income | 190 | -58 | 274 | 2,267 | 3,838 |
| Pre-tax Income | -1,340 | -500 | -2,266 | -721 | 786 |
| Net Income Continuous | -1,340 | -500 | -2,266 | -901 | 786 |
| Net Income Discontinuous | -2 | -4 | -1 | -3 | 545 |
| Net Income | $-1,342 | $-504 | $-2,268 | $-903 | $1,331 |
| EPS Basic Total Ops | 0.00 | -0.11 | -28.71 | 2,298,422.00 | -5,881.55 |
| EPS Basic Continuous Ops | 0.00 | -0.11 | -28.71 | 2,303,796.00 | -5,893.97 |
| EPS Basic Discontinuous Ops | 0.00 | 0.00 | 0.00 | -5,373.84 | 12.42 |
| EPS Diluted Total Ops | 0.00 | -0.11 | -28.71 | 2,298,422.00 | -5,881.55 |
| EPS Diluted Continuous Ops | 0.00 | -0.11 | -28.71 | 2,303,796.00 | -5,893.97 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.00 | 0.00 | -5,373.84 | 12.42 |
| EPS Diluted Before Non-Recurring Items | 0.00 | -0.11 | -28.71 | N/A | N/A |
| EBITDA(a) | $-807 | $154 | $-1,803 | $-2,176 | $-2,244 |